| 1 |
Dixon BP, Sabus A. Ravulizumab 100 mg/mL formulation reduces infusion time and frequency, improving the patient and caregiver experience in the treatment of atypical haemolytic uraemic syndrome. J Clin Pharm Ther 2022. [PMID: 35304755 DOI: 10.1111/jcpt.13642] [Reference Citation Analysis]
|
| 2 |
Ávila A, Gavela E, Sancho A. Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity. Front Med (Lausanne) 2021;8:642864. [PMID: 33898482 DOI: 10.3389/fmed.2021.642864] [Reference Citation Analysis]
|
| 3 |
Chand DH, Zaidman C, Arya K, Millner R, Farrar MA, Mackie FE, Goedeker NL, Dharnidharka VR, Dandamudi R, Reyna SP. Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series. The Journal of Pediatrics 2021;231:265-8. [DOI: 10.1016/j.jpeds.2020.11.054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 4 |
Cody EM, Dixon BP. Hemolytic Uremic Syndrome. Pediatric Clinics of North America 2019;66:235-46. [DOI: 10.1016/j.pcl.2018.09.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 5 |
Chiruvolu NV, Scott J, Yeh SS. An Imperfect Marker: SLE and TTP-Like MAHA Without Low ADAMTS13. J Investig Med High Impact Case Rep 2021;9:23247096211029746. [PMID: 34229453 DOI: 10.1177/23247096211029746] [Reference Citation Analysis]
|
| 6 |
Fernandez HE, Foster BJ. Long-Term Care of the Pediatric Kidney Transplant Recipient. Clin J Am Soc Nephrol 2021:CJN. [PMID: 33980614 DOI: 10.2215/CJN.16891020] [Reference Citation Analysis]
|
| 7 |
Gomes SM, Teixeira RP, Rocha G, Soares P, Guimaraes H, Santos P, Jardim J, Barreira JL, Pinto H. Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era. AJP Rep 2021;11:e95-8. [PMID: 34178424 DOI: 10.1055/s-0041-1731057] [Reference Citation Analysis]
|
| 8 |
Çelakil ME, Yücel BB, Bek K. CFH and CFB mutations in Shiga toxin-associated haemolytic uraemic syndrome in a 6-year-old boy. Paediatr Int Child Health 2020;40:129-31. [PMID: 31242818 DOI: 10.1080/20469047.2019.1616458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 9 |
Bello-Marquez DC, Nieto-Rios JF, Serna-Higuita LM, Gonzalez-Vergara AJ. Nephrotic syndrome associated with primary atypical hemolytic uremic syndrome. J Bras Nefrol 2021;43:440-4. [PMID: 32779691 DOI: 10.1590/2175-8239-JBN-2020-0050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 10 |
Cheng C, Chen L, Wen S, Lin Z, Jiang X. Case Report: Denys-Drash Syndrome With WT1 Causative Variant Presenting as Atypical Hemolytic Uremic Syndrome. Front Pediatr 2020;8:605889. [PMID: 33392118 DOI: 10.3389/fped.2020.605889] [Reference Citation Analysis]
|
| 11 |
Siddon AJ, Tormey CA. The chemical and laboratory investigation of hemolysis. Adv Clin Chem 2019;89:215-58. [PMID: 30797470 DOI: 10.1016/bs.acc.2018.12.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 12 |
Gholizad-Kolveiri S, Hooman N, Alizadeh R, Hoseini R, Otukesh H, Talebi S, Akouchekian M. Whole exome sequencing revealed a novel homozygous variant in the DGKE catalytic domain: a case report of familial hemolytic uremic syndrome. BMC Med Genet 2020;21:169. [PMID: 32838746 DOI: 10.1186/s12881-020-01097-9] [Reference Citation Analysis]
|
| 13 |
Witte D, Hartmann H, Drube J, Haffner D, Illsinger S. [Thrombotic Microangiopathy (TMA) after Gene Replacemant Therapy (GRT) due to Spinal Muscular Atrophy: Case Summary and Recommendations for Treatment]. Klin Padiatr 2021. [PMID: 34388834 DOI: 10.1055/a-1538-4936] [Reference Citation Analysis]
|
